Skip to main content

Table 2 IPF prevalence estimates per country

From: Global incidence and prevalence of idiopathic pulmonary fibrosis

Country

Study

Publication year

Mean unadjusted prevalence (per 10,000)

Adjusted prevalence (per 10,000)

95% CI Adjusted prevalence (per 10,000)

Rare disease threshold (per 10,000)

Rare disease threshold met?

Asia–Pacific

 Japan

Kondoh et al. [42]

2016

0.59

0.89

(0.51, 1.55)

< 50,000 casesa [25]

NA

Natsuizaka et al. [45]

2014

1.00

Combined

 

0.79

 South Korea

Kim et al. [41]

2017

3.52

4.51

(2.99, 6.79)

< 20,000 casesa [26]

NA

Lee et al. [44]

2016

3.89

Combined

 

3.70

 Taiwan

Lai et al. [43]

2012

0.49

0.57

(0.34, 0.94)

1 [27]

Yes

Europe

 Denmark

Hyldgaard et al. [39]

2014

1.01

1.17

(0.56, 2.44)

1–2 [28]

Yes (upper CI out of bounds)

 Finland

Kaunisto et al. [40]

2015

0.86

0.65

(0.36, 1.18)

5 [29]

Yes

 France

Duchemann et al. [35]

2017

0.82

0.94

(0.44, 1.99)

5 [29]

Yes

 Greece

Karakatsani et al. [52]

2009

0.34

0.33

(0.21, 0.53)

5 [29]

Yes

 Italy

Agabiti et al. [33]

2014

2.56

2.37

(1.38, 4.09)

5 [29]

Yes

Harari et al. [37]

2016

2.12

Combined

 

2.46

 Poland

Szafrański [50]

2012

2.56

2.51

(1.55, 4.05)

5 [29]

Yes

 United Kingdom

Strongman et al. [13]

2018

1.16

0.78

(0.38, 1.63)

5 [29]

Yes

North America

 Canada

Hopkins et al. [38]

2016

2.00

2.98

(1.7, 5.19)

5 [30]

Yes (upper CI out of bounds)

Tarride et al. [12]

2018

7.27

Combined

 

2.98

 United States

Fernández Pérez et al. [11]

2010

2.81

2.4

(1.33, 4.34)

< 200,000a [31]

Yes

Raghu et al. [47]

2014

11.1

Raghu et al. [46]

2016

0.67

Combined

 

1.37

  1. CI confidence interval, IPF idiopathic pulmonary fibrosis, NA not applicable
  2. aNumber of cases provided rather than threshold